1. Introduction

Living-robot hybrid systems, also called biohybrid robots, are systems that combine living biological materials with engineered robotic components. They may incorporate living cells, muscle tissue, neurons, microorganisms, artificial sensors, electronic circuits, or mechanical structures to perform particular tasks.

Examples include:

Living-cell robots: Small structures made from living cells that can move or respond to their environment.

Biohybrid machines: Robotic devices powered by living muscle tissue.

Neural-interface robots: Systems connecting biological neural tissue with electronic or mechanical devices.

Microorganism-powered systems: Engineered devices that use biological activity for movement, sensing, or energy conversion.

Xenobots - the tiny robots with enormous potential - ABC listen

Lab-grown living muscles help robots lift a finger

Organismal Engineering: Towards a Robotic Taxonomic Key for Devices Using Organic Materials - PMC

11

The central legal question is whether such a system should be classified as a machine, biological organism, regulated research material, medical device, product, or independent legal person.

There is no single universal classification. The answer depends on the system's biological composition, degree of integration, intended use, capacity to reproduce or survive, and potential risks to people and the environment.

Important legal position: As of November 2026, there is no generally recognised legal category that automatically gives living-robot hybrids independent legal personality. Existing laws generally regulate the system through its components, use, ownership, manufacture, research activities, and effects on others. Legal scholarship also distinguishes the question of whether an entity is biologically alive from whether the law should treat it as a legal person.

Frontiers+1

2. Meaning and scope of legal classification

Legal classification is the process of deciding which legal rules apply to an entity and which rights, duties, permissions, and liabilities follow from that classification.

A living-robot hybrid may fall into several overlapping categories.

These categories are not mutually exclusive. For example, a robot containing engineered living cells could simultaneously be a manufactured product, a regulated biological system, and a medical device.

3. Principal legal theories

A. The object-based approach

Under this approach, the hybrid is treated as an object or instrument controlled by a human being or organisation. Its actions are attributed to legally responsible parties rather than to the system itself.

This is generally the most practical starting point for conventional biohybrid robots.

B. The biological-regulation approach

This approach focuses on the living component. Relevant questions include whether the system contains genetically modified organisms, whether it can reproduce, whether it could escape containment, and whether it presents ecological or health risks.

A robot does not cease to be subject to biological regulation simply because its cells are attached to a mechanical structure.

C. The functional approach

Under a functional approach, legal classification depends on what the system does rather than merely what it is made of.

For example, the same biohybrid platform might be subject to different requirements when used for laboratory research, environmental remediation, or treatment inside the human body.

D. The legal-personhood approach

Some legal scholars have considered whether sufficiently autonomous artificial systems should receive limited legal personality. However, autonomy, responsiveness, learning, or the presence of living cells does not by itself confer legal personality.

The academic literature identifies legal personhood as a legal instrument that may be created for specific purposes, not an automatic consequence of technological sophistication.

DOI+1

4. Indian legal framework

India does not have a single comprehensive statute specifically classifying living-robot hybrid systems. The applicable legal regime depends on whether the system involves genetic engineering, medical use, biological research, personal data, or environmental release. India's existing biotechnology and environmental laws are therefore particularly important.

Chambers and Partners+1

A. Environment (Protection) Act, 1986

The Act provides a broad framework for environmental protection. Where a living-robot hybrid incorporates regulated genetically engineered organisms or hazardous microorganisms, its research, manufacture, handling, or release may attract relevant statutory requirements.

Key provisions include:

Section 3: Central Government powers to take measures to protect and improve environmental quality.

Section 6: Power to make rules concerning environmental protection.

Section 8: Handling of hazardous substances in accordance with prescribed safeguards.

The precise application depends on the biological material, activity, and applicable rules.

India Code+1

B. Genetically Engineered Organisms Rules, 1989

The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-Organisms/Genetically Engineered Organisms or Cells, 1989, are especially relevant when a hybrid incorporates genetically engineered cells or organisms covered by the Rules.

The regulatory framework includes the Review Committee on Genetic Manipulation (RCGM) and the Genetic Engineering Appraisal Committee (GEAC), among other competent authorities.

Depending on the proposed activity, regulatory questions may include:

Whether the living component falls within the Rules.

Whether research or contained use requires institutional or regulatory oversight.

Whether manufacture, import, transport, or sale requires approval.

Whether environmental release or large-scale use is permissible.

Whether appropriate containment and risk-management measures are in place.

The Rules do not automatically apply to every robot containing biological material; their statutory scope must be established in each case.

ibkp.dbt.gov.in+2

C. Medical-device and biomedical-research regulation

If a biohybrid system is intended for diagnosis, treatment, rehabilitation, or another medical purpose, the Medical Devices Rules, 2017, may apply to the device or relevant components, depending on their intended purpose and classification.

If the system incorporates investigational biological products, human tissues, or research involving human participants, additional requirements under the applicable drugs, clinical-trial, biomedical-research, and ethics frameworks may be relevant.

For example, a muscle-powered robotic implant presents different regulatory questions from an experimental cell-based robot operating exclusively in a laboratory.

D. Data protection and privacy

Where a hybrid system collects identifiable health, physiological, or neural data, applicable privacy and data-protection obligations must also be considered. The Digital Personal Data Protection Act, 2023, is relevant where its provisions apply to the processing of digital personal data.

The legal classification of the physical robot does not determine the legal status of all data it collects.

E. Property, contracts, and intellectual property

Ownership of the machine does not necessarily settle ownership or lawful control of its biological components.

Contracts should distinguish between:

The physical hardware and software.

Biological materials and any applicable restrictions on their transfer.

Research results, inventions, and confidential information.

Duties relating to maintenance, containment, disposal, and incident reporting.

Patent eligibility must be assessed under the applicable patent statute. The fact that a system contains living material does not automatically make the complete hybrid patentable.

5. Important case laws and their relevance

There is an important limitation: the leading cases below do not directly decide the legal classification of living-robot hybrid systems. They establish principles concerning biological materials, engineered organisms, environmental risk, and artificial-system legal status that may be applied by analogy.

Case 1: Vellore Citizens' Welfare Forum v. Union of India (1996)

Supreme Court of India · (1996) 5 SCC 647

Facts: The case concerned industrial pollution caused by tanneries in Tamil Nadu and the resulting damage to water resources, agricultural land, and the environment.

Decision: The Supreme Court recognised the precautionary principle and the polluter-pays principle as part of Indian environmental law. It emphasised that environmental protection may require preventive action even where scientific uncertainty remains.

Application to living-robot hybrids: If a hybrid organism could escape containment, reproduce, disrupt an ecosystem, or cause serious biological harm, regulators could draw on these principles when assessing environmental risks.

Legal significance: Scientific uncertainty is not necessarily a justification for delaying appropriate environmental safeguards.

VoxJuris+1

Case 2: A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

Supreme Court of India · (1999) 2 SCC 718

Facts: The dispute involved environmental clearance and the scientific assessment of a proposed industrial activity.

Decision: The Court examined the precautionary principle, the limits of scientific certainty, and the importance of specialised scientific expertise in environmental decision-making.

Application to living-robot hybrids: A regulatory authority assessing a genetically engineered biohybrid should consider expert evidence concerning biological persistence, genetic stability, toxicity, containment failure, and possible environmental consequences.

Legal significance: Complex scientific uncertainty may require specialised expertise and preventive risk assessment rather than reliance solely on conventional evidence of existing harm.

Indian Kanoon+1

Case 3: Moore v. Regents of the University of California (1990)

Supreme Court of California, United States · 51 Cal. 3d 120; 793 P.2d 479

Facts: John Moore challenged the use of cells removed from his body for research and commercial development without adequate disclosure of the relevant interests.

Decision: The court rejected his conversion claim based on the excised cells under the circumstances, while recognising the significance of disclosure and fiduciary duties in the physician-patient relationship.

Application to living-robot hybrids: The case raises questions about whether a donor's biological material may be incorporated into a commercially valuable system and what consent, disclosure, or contractual rights may survive the transfer.

Legal significance: Ownership of a device and legal interests in the biological material used to create it are distinct questions. The decision does not establish a universal rule that all human biological materials may be freely commercialised. This is a United States decision, not binding Indian precedent.

Case 4: Diamond v. Chakrabarty (1980)

Supreme Court of the United States · 447 U.S. 303

Facts: The case concerned a genetically engineered bacterium capable of breaking down multiple components of crude oil and the eligibility of that organism for patent protection.

Decision: The Court held that the engineered microorganism fell within the relevant United States patent statute's scope because it was a human-made manufacture or composition of matter, rather than merely a naturally occurring organism.

Application to living-robot hybrids: A deliberately engineered biological component may raise different intellectual-property questions from a naturally occurring organism. A hybrid's patent eligibility would depend on the relevant claims and statutory requirements.

Legal significance: Patent eligibility does not establish legal personhood, and the decision does not mean that every living organism or biohybrid is patentable. The decision concerns United States patent law; Indian patent law has its own statutory exclusions and requirements.

Case 5: Association for Molecular Pathology v. Myriad Genetics, Inc. (2013)

Supreme Court of the United States · 569 U.S. 576

Facts: The case concerned patents over isolated DNA sequences associated with breast and ovarian cancer.

Decision: The Court held that naturally occurring DNA does not become patent-eligible merely because it has been isolated, while synthetically created cDNA may be patent-eligible in the circumstances considered.

Application: The decision illustrates the distinction between naturally occurring biological material and human-created technological innovations. For biohybrid robotics, the biological component, engineered structure, and claimed invention must be examined separately.

Legal significance: The presence of biological material does not itself settle patent eligibility. This US judgment is persuasive only by analogy when considering the distinct requirements of Indian patent law.

Case 6: Thaler v. Vidal (2022)

United States Court of Appeals for the Federal Circuit · 43 F.4th 1207

Facts: Stephen Thaler sought patent protection for inventions attributed to an artificial intelligence system named DABUS.

Decision: The court held that, under the relevant US Patent Act, an inventor must be a natural person.

Application: Even if a living-robot hybrid exhibits adaptive behaviour or generates technically useful results, its operational autonomy does not automatically make it an inventor or an independent legal subject.

Legal significance: Inventorship and legal personality are determined by applicable law, not simply by a system's capabilities. The decision does not directly concern biological robots and is not binding in India.

6. Liability for harm caused by a living-robot hybrid

Legal classification determines which parties may bear responsibility when a hybrid causes injury or damage.

Consider a research laboratory that develops a biohybrid robot containing genetically engineered cells. The robot escapes its containment environment and damages a neighbouring agricultural facility.

Potentially responsible parties could include:

Manufacturer: Defective construction, inadequate containment design, or failure to provide appropriate warnings.

Developer: Negligent engineering, inadequate testing, or failure to address foreseeable risks.

Laboratory or operator: Unsafe handling, insufficient supervision, or breach of applicable containment requirements.

Institution or company: Organisational failures, inadequate safety procedures, or breaches of statutory duties.

Supplier: Defective components or failures to meet contractual or statutory obligations.

Liability would depend on the evidence, applicable legislation, contractual relationships, causation, and the conduct of each party. The robot's autonomy would not, by itself, eliminate the responsibility of those who designed, supplied, controlled, or deployed it.

In India, potential legal routes include negligence and other applicable tort principles, the Consumer Protection Act, 2019, where relevant, environmental legislation, and specific statutory offences. There is no established general rule imposing automatic liability on a living-robot hybrid as an independent legal person.

7. Ownership and intellectual-property disputes

Three separate questions should be distinguished.

For example, a university might own a robotic platform, while a biotechnology company supplies the engineered cells under a research licence. The licence may restrict the cells' use, prohibit onward transfer, or require special disposal procedures.

Ownership of the platform would not automatically extinguish those restrictions. Nor would ownership of biological material automatically confer ownership of every invention created using it.

8. Constitutional and ethical considerations

Legal classification must also account for the people and communities affected by the technology.

In India, the following constitutional principles may be relevant:

Article 21: Protection of life and personal liberty, including applicable interests in bodily integrity and privacy.

Article 14: Equality before the law and protection against arbitrary state action.

Article 48A: The State's duty to protect and improve the environment.

Article 51A(g): The fundamental duty to protect the natural environment and show compassion for living creatures.

These provisions do not automatically grant constitutional rights to a biohybrid robot. Instead, they may inform the regulation of research, the protection of people, and the prevention of environmental harm.

Ethical review may also be necessary where research involves human-derived cells, human participants, animal-derived tissues, or other materials governed by specific ethical and regulatory requirements.

9. Recommended legal classification framework

A proportionate regulatory framework should classify living-robot hybrids according to biological risk, intended function, and operational capability rather than using a single label for every system.

Class I — Contained research hybrids

Examples: non-replicating cell-based robots confined to laboratory experiments.

Emphasis on institutional oversight, biosafety, handling procedures, and research ethics where applicable.

Class II — Controlled operational hybrids

Examples: muscle-powered robotic devices or biological sensors used in controlled industrial settings.

Emphasis on product safety, operator training, containment where required, traceability, and incident reporting.

Class III — Medical or human-integrated hybrids

Examples: experimental implants incorporating living tissue and electronic control systems.

Emphasis on applicable medical-device or biological-product regulation, clinical evidence, informed consent, and patient safety.

Class IV — Environmentally deployable or high-risk hybrids

Examples: systems containing engineered organisms intended for environmental deployment.

Emphasis on environmental risk assessment, appropriate authorisations, containment or recovery plans, monitoring, and remediation.

These four classes are a proposed analytical framework, not an existing statutory classification in India. A system may fall within more than one class, and classification would not replace any applicable regulatory approval.

10. Conclusion

The legal classification of living-robot hybrid systems requires a combination of property law, biotechnology regulation, product liability, intellectual-property law, environmental protection, and, where applicable, medical and data-protection law.

The principal conclusions are:

A biohybrid robot is not automatically a legal person merely because it contains living cells or displays autonomous behaviour.

Its biological components may trigger regulatory requirements independently of the robotic hardware.

Ownership of the physical device does not necessarily confer unrestricted rights over biological materials or research results.

Existing Indian environmental decisions, particularly Vellore Citizens' Welfare Forum and A.P. Pollution Control Board v. Prof. M.V. Nayudu, provide relevant principles for precautionary regulation and scientific risk assessment.

The cases discussed do not establish a binding judicial classification specifically for living-robot hybrids. The field remains dependent on applying existing law to new technological circumstances.

Overall legal position: The most defensible starting point is to classify a living-robot hybrid according to its components, function, risks, and intended use, while retaining clear legal accountability for the humans and organisations responsible for its development and deployment.

This is a general academic legal analysis, with particular emphasis on India. Specific regulatory conclusions require examination of the particular system, its biological composition, intended use, and the laws in force at the relevant time.